… The aim of the study was to establish eventual progress in routine management of … of the
study was to establish eventual progress in routine management of all lung cancer patients over …

… cell lung cancer (NSCLC) accounts for ∼80% of all cases of lung cancer and it is estimated
that ∼55% of patients present with inoperable disease at the time of diagnosis [stage tumor–…

… -small cell lung cancer (NSCLC) patients confers a worse quality of life and prognosis. The
efficacy comparison … NSCLC patients with EGFR-sensitizing mutations is yet to be elucidated. …

… survival has grown to be a popular area of research among medical and computer science
experts. This study aims to predict the survival period of lung cancer patients using 12 …

… )-rearranged lung tumours … cells (CTCs) isolated from patients with lung cancer has not
been characterised. We assessed the ALK status in CTCs detected in patients with lung cancer …

Between 1981 and 1986, a total of 46 patients with small cell lung cancer (SCLC) achieving
a complete response by chemotherapy with or without chest irradiation were randomized …

Objectives Genotype-guided personalized therapy has become an essential part of routine
clinical care in non-small cell lung cancer (NSCLC) patients. However, small tissue …

… In parallel, we analyzed clinicopathologic and genomic data from 3,560 patients with non–small
cell lung cancer (NSCLC) to survey allele-specific features associated with oncogenic …

… Patient's characteristics A total of 190 patients with resected lung adenocarcinoma were
included in the present analysis: 147 patients were current or former smokers and 43 …

… /4-methotrexate immunoconjugate in patients with Stage IIIB or IV non-small cell
carcinoma of the lung. Six patients received KS1/4 alone and five patients received KS1/4-methotrexate …